期刊文献+

5-氮杂-2’-脱氧胞苷和曲古菌素A对胰腺癌Panc-1细胞系TFPI-2基因甲基化水平及表达的影响

Effects of 5-aza-2' -deoxycytldme and trichostatin A on the methylation and expression of TFPI-2 gene in human pancreatic cancer Panc-1 cell line
原文传递
导出
摘要 目的探讨甲基化酶抑制剂5-氮杂-2L脱氧胞苷(5-AzadC)及组蛋白去乙酰化酶抑制剂曲古菌素A(TSA)对胰腺癌Panc-1细胞系中TFPI-2基因甲基化水平及基因表达的影响。方法单独或联合应用5-Aza—dC及TSA处理Panc-1细胞,应用甲基化特异性聚合酶链反应、逆转录聚合酶链反应及蛋白印迹实验检测药物处理前后Panc-1细胞TFPI-2基因启动子区甲基化状态、mRNA及蛋白表达情况。结果经5-Aza-dC单独处理或5-Aza—dC及TSA联合处理Panc-1细胞后,TFPI-2基因启动子区高甲基化状态得到逆转,表现为非甲基化,原本不表达的TFPI-2基因mRNA及蛋白重新表达,两组作用效果相似。经TSA单独处理的Panc-1细胞TFPI-2基因启动子区仍为异常高甲基化状态,原本不表达的TFPI2基因未见重新表达。结论胰腺癌Panc1细胞系中TFPI-2基凶启动子区高甲基化可能是导致该基因失活的主要原因,5Aza—dC单独作用或与TSA联合作用均能逆转TFPI-2基因的高甲基化状态,使该基因重新表达。 Objective To investigate effects of 5 aza-2'-deoxycytidine (5-Aza dC) and trichosta- tin A (TSA) on the methylation and expression of TFPI-2 gene in pancreatic cancer Panc-1 cells. Methods We treated pancreatic cancer Pane-1 cells with 5-Aza-dC and TSA alone or combined. TFPI- 2 gene's DNA, mRNA and protein were determined by MSP, RT-PCR and Western blot. Results The hypermethylation of TFPI-2 gene in Pane-1 ceils was reversed after treated with 5-Aza-dC alone or in combination with TSA. The re-introduction or raised expression of TFPI-2 mRNA and protein was detected in Pane-1 cells after treated with 5 Aza-dC alone or in combination. However, we did not see the hypermethylation of TFPI-2 gene reversed nor detected TFPI-2 gene mRNA and protein after treated with TSA alone. Conclusions The methylation of the promoter region for the TFPI-2 gene is a main cause for its transcriptional activation in Pane-1 cells. The hypermethylation of TFPI-2 gene in Panc 1 cell was reversed and the expression of TFPI-2 gene mRNA and protein was detected after trea ted with S-Aza-dC alone or in combination with TSA. Treatment of TSA alone does not have significant effect on TFPI-2 gene reexpression.
作者 汤志刚 郑浩
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2012年第3期226-229,共4页 Chinese Journal of Hepatobiliary Surgery
基金 基金项目:国家自然科学基金(81071734)
关键词 胰腺肿瘤 基因表达 曲古菌素A Pancreatic neoplasms Gene expression Trichostatin A
  • 相关文献

参考文献12

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics[J]. CA Cancer J Clin, 2009, 59:225 249.
  • 2张太平,展翰翔,赵玉沛.以规范化手术及综合治疗为策略改善胰腺癌预后[J].中华肝胆外科杂志,2011,17(6):441-443. 被引量:17
  • 3Hruban RH, Iacobuzio-Donahue C, Wilentz RE, et al. Molec ular pathology of pancreatic cancer[J]. Cancer J, 2001, 7: 251-258.
  • 4Ueki T, Toyota M, Sohn T, et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma [J]. Cancer Res, 2000, 60:1835-1839.
  • 5Hellebrekers DM, Jair KW, Vire E, et al. Angiostatic activity of DNA methyltransferase inhibitors[J]. Mol Cancer Ther, 2006, 5:467-475.
  • 6Chan AO, Rashid A. CpG island methylation in precursors of gastrointestinal malignan-cies[J]. Curr Mol Med, 2006, 6: 401-408.
  • 7Konduri SD, Srivenugopal KS, Yanamandra N, et al. Pro moter methylation and silencing of the tissue factor pathway inhibitor-2, a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells[J]. Oneogene, 2003, 22: 4509-4516.
  • 8刘小方,许政,张浩,苏海龙,李绍军,周先亭,宋占文,孙孚波.胆管癌TMS1/ASC基因甲基化及其临床意义[J].中华肝胆外科杂志,2007,13(11):783-784. 被引量:2
  • 9Jones PA. DNA methylation errors and cancer[J]. Cancer Res, 1996, 56:2463-2467.
  • 10Donadelli M, Costanzo C, Faggioli L, et al. Trichostatin A,an inhibitor of histone deacetylases,strongly suppresses growth of pancreatic adenocarcinoma cells[J]. Mol Carcinog, 2003, 38: 59-69.

二级参考文献35

  • 1刘小方,张浩,孔凡民,大塜隆生,宫崎耕治.大肠癌中TMS1/ASC基因甲基化及意义[J].中华实验外科杂志,2005,22(5):628-628. 被引量:5
  • 2Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin, 2009,59:225-249.
  • 3Hidalgo M. Pancreatic cancer. N Engi J Med, 2010, 362: 1605-1617.
  • 4Bilimoria KY, Bentrem DJ, Ko CY, et al. National failure to operate on early stage pancreatic cancer. Ann Surg, 2007, 246 : 173-180.
  • 5Larghi A, Verna EC, Lecca PG, et al. Screening for pancreat ic cancer in high-risk individuals: a call for endoscopic ultra- sound. Clin Cancer Res, 2009,15 : 1907-1914.
  • 6Gemmel C, Eickhoff A, Helmstadter L, et al. Pancreatic cancer screening: state of the art. Expert Rev Gastroenterol Hepatol, 2009,3 : 89-96.
  • 7Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Border- line reseetable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol, 2006,13: 1035-1046.
  • 8Katz MH, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg, 2008,206:833-846 ; discussion 846-838.
  • 9Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg, 2007,246 :52 -60.
  • 10Evans DB, Farnell MB, Lillemoe KD, et al. Surgical treatment of resectable and borderline resectable pancreas cancer: expert con sensus statement. Ann Surg Oncol, 2009,16 : 1736-1744.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部